• Adia Med sold seven membership units in Adia Labs to CEO Larry A. Powalisz on October 13, 2026.
• The $350,000 all-cash purchase represents a 7% membership interest with 7% of voting power.
• Use of proceeds requires joint written approval from independent directors Monica Sher and Richard Edwards.
• Powalisz has no unilateral authority over the proceeds, which are restricted to corporate purposes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adia Med Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-26-007951), on October 19, 2026, and is solely responsible for the information contained therein.